Authors:
Arvieux, J
Regnault, V
Hachulla, E
Darnige, L
Berthou, F
Youinou, P
Citation: J. Arvieux et al., Oxidation of beta(2)-glycoprotein I (beta(2)GPI) by the hydroxyl radical alters phospholipid binding and modulates recognition by anti-beta(2)GPI autoantibodies, THROMB HAEM, 86(4), 2001, pp. 1070-1076
Authors:
Vallar, L
Regnault, V
Latger-Cannard, V
Lecompte, T
Citation: L. Vallar et al., beta(2)-glycoprotein I binding to platelet microparticle membrane specifically reduces immunoreactivity of glycoproteins IIb/IIIa, THROMB HAEM, 85(2), 2001, pp. 314-319
Authors:
Guermazi, S
Regnault, V
Gorgi, Y
Ayed, K
Lecompte, T
Dellagi, K
Citation: S. Guermazi et al., Further evidence for the presence of anti-protein S autoantibodies in patients with systemic lupus erythematosus, BL COAG FIB, 11(5), 2000, pp. 491-498
Authors:
Latger-Cannard, V
Regnault, V
Dumas, D
Nguyen, P
Lecompte, T
Stoltz, JF
Citation: V. Latger-cannard et al., Determination of polymorphonuclear neutrophil adhesion receptors: Influence of pre-analytic factors., J MAL VASC, 25(3), 2000, pp. 181-186
Authors:
Regnault, V
De Maistre, E
Wahl, D
Lecompte, T
Citation: V. Regnault et al., Monovalent binding of autoantibodies to beta(2)-glycoprotein I, detected using surface plasmon resonance at low antigen density, BR J HAEM, 109(1), 2000, pp. 187-194
Authors:
Vallar, L
Melchior, C
Plancon, S
Drobecq, H
Lippens, G
Regnault, V
Kieffer, N
Citation: L. Vallar et al., Divalent cations differentially regulate integrin alpha(IIb) cytoplasmic tail binding to beta(3) and to calcium- and integrin-binding protein, J BIOL CHEM, 274(24), 1999, pp. 17257-17266
Authors:
Regnault, V
Arvieux, J
Vallar, L
Lecompte, T
Citation: V. Regnault et al., Both kinetic data and epitope mapping provide clues for understanding the anti-coagulant effect of five murine monoclonal antibodies to human beta(2)-glycoprotein I, IMMUNOLOGY, 97(3), 1999, pp. 400-407
Authors:
Arvieux, J
Pernod, G
Regnault, V
Darnige, L
Garin, J
Citation: J. Arvieux et al., Some anticardiolipin antibodies recognize a combination of phospholipids with thrombin-modified antithrombin, complement C4b-binding protein, and lipopolysaccharide binding protein, BLOOD, 93(12), 1999, pp. 4248-4255